BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 1999
View Archived Issues
Pfizer: Q4 1998 highlights
Read More
Alza's 1998 milestones, priorities for 1999
Read More
LeukoSite acquisition of CytoMed completed
Read More
Company Profile: Pentagenic Pharmaceuticals
Read More
Ariad achieves second milestone in HMR collaboration
Read More
Second U.S. patent allowed for Antex Biologics' H. pylori vaccine
Read More
Incyte and ICAgen collaborate on ion channel R&D
Read More
NO synthase inhibition reduces chronic tension headache pain
Read More
Idec Pharmaceuticals announces three new cancer research collaborations
Read More
Available for licensing from VUFB: dopamine agonist for dermatology, gastrointestinal indications
Read More
Novel antihypertensive drug candidate available for licensing from VUFB
Read More
FDA approves Chiron's newest HCV diagnostic test
Read More
Genzyme's oncology division in-licenses angiogenesis inhibitor for development
Read More
Biostar initiates phase I/II trial of Norelin in prostate cancer patients and creates subsidiary
Read More
Isis Pharmaceuticals: Q4 and year-end 1998 highlights
Read More
Dopamine D4-selective compounds, therapeutic and diagnostic uses disclosed by Resolution
Read More
Potent bradykinin antagonists developed at Fournier
Read More
Boehringer Ingelheim researches thrombin inhibitors
Read More
Protein farnesyltransferase inhibitors in development at Bristol-Myers Squibb
Read More
Novel antioxidant/antiproliferative NSAID esters and amides designed by Alcon
Read More
New test for Lyme disease approved by FDA
Read More
Astra's P2T receptor antagonists offer significant potential as novel antithrombotics
Read More
Quark Biotech enters research agreement with Sankyo for diabetes drug
Read More
Lilly cancels Targretin development program in diabetes with Ligand
Read More
New broad-based malaria vaccine shows positive results
Read More